Director/PDMR Shareholding

RNS Number : 1418U

GlaxoSmithKline PLC

27 July 2015

 

GlaxoSmithKline plc

 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibilities or Connected Persons

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the Plan) notified the Company and the under-mentioned Directors, Persons Discharging Managerial Responsibilities ('PDMR') and Connected Persons on 24 July 2015 of the following increases in their notional interests in Ordinary Shares at a price of 1369.00 pence per Ordinary Share and American Depositary Shares ('ADSs') at a price of $41.80 per ADS following the notional re-investment of the dividend paid to shareholders on 9 July 2015.

Director/PDMR	Ordinary Shares	ADSs
Sir Andrew Witty	18997.185
Dr M M Slaoui		5596.705
Mr S Dingemans	8251.600
Mr R G Connor	3700.161
Mr N Hirons	592.901	205.521
Mr S A Hussain	7756.471
Mr W C Louv		1641.746
Mr D S Redfern	2813.799
Ms C Thomas	3910.257
Mr P C Thomson	1996.718
Mr D E Troy		3481.744
Dr P J T Vallance	8326.341
Ms E Walmsley	4816.457
Mrs V A Whyte	524.954

Connected Person	Ordinary Shares	ADSs
Dr K Slaoui (Connected Person to Dr M M Slaoui)		90.534
Mrs K Thomson (Connected Person to Mr P C Thomson)	49.550

The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).

V A Whyte

Company Secretary

27 July 2015

 

END

 

 

RDSVDLBLEDFBBBQ